Terry Pearson
Technik-/Wissenschafts-/F&E-Leiter bei Siscapa Assay Technologies, Inc.
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Deborah Rathjen | M | - | 7 Jahre | |
| Wilfred A. Jefferies | M | 65 |
Eyam Vaccines & Immunotherapeutics Ltd.
CAVA Healthcare, Inc.
 CAVA Healthcare, Inc. Food: Specialty/CandyConsumer Non-Durables CAVA Healthcare, Inc. operates as a early stage biotechnology company. The company is headquartered in Surrey, Canada. | - |
| Adrian P. Wade | M | - |
CAVA Healthcare, Inc.
CAVA Healthcare, Inc. Food: Specialty/CandyConsumer Non-Durables CAVA Healthcare, Inc. operates as a early stage biotechnology company. The company is headquartered in Surrey, Canada. | 8 Jahre |
| Theo Warkentin | M | - |
Eyam Vaccines & Immunotherapeutics Ltd.
CAVA Healthcare, Inc.
CAVA Healthcare, Inc. Food: Specialty/CandyConsumer Non-Durables CAVA Healthcare, Inc. operates as a early stage biotechnology company. The company is headquartered in Surrey, Canada. | 4 Jahre |
| Gustavo Salem | M | 60 |
Siscapa Assay Technologies, Inc.
 Siscapa Assay Technologies, Inc. BiotechnologyHealth Technology Siscapa Assay Technologies, Inc. provides products and services for precise quantitation of protein biomarkers, drugs, and drug targets using immuno-affinity mass spectrometry. Siscapa assays are used in clinical diagnostics and pharma R&D for particularly demanding applications, and in biomarker panels to characterize changes in health, disease, and treatment in longitudinal user-collected dried blood microsamples. Siscapa immuno-affinity mass spectrometry assays for targeted protein quantitation can be developed more quickly than typical ELISA immunoassays since they require only a single specific antibody and provide absolute target specificity because of the MS detection. Because Siscapa assays do not interact with one another, these assays can be freely assembled in panels for various applications. The American company was founded by N. Leigh Anderson, who has been the CEO since incorporation. | 10 Jahre |
| Ryan M. Thomas | M | - |
Eyam Vaccines & Immunotherapeutics Ltd.
| 4 Jahre |
| Jamie Kirwin | F | - |
CAVA Healthcare, Inc.
CAVA Healthcare, Inc. Food: Specialty/CandyConsumer Non-Durables CAVA Healthcare, Inc. operates as a early stage biotechnology company. The company is headquartered in Surrey, Canada. | 3 Jahre |
| Roslyn Ritchie-Derrien | F | 61 |
Eyam Vaccines & Immunotherapeutics Ltd.
CAVA Healthcare, Inc.
CAVA Healthcare, Inc. Food: Specialty/CandyConsumer Non-Durables CAVA Healthcare, Inc. operates as a early stage biotechnology company. The company is headquartered in Surrey, Canada. | 4 Jahre |
| N. Anderson | M | 74 |
Siscapa Assay Technologies, Inc.
Siscapa Assay Technologies, Inc. BiotechnologyHealth Technology Siscapa Assay Technologies, Inc. provides products and services for precise quantitation of protein biomarkers, drugs, and drug targets using immuno-affinity mass spectrometry. Siscapa assays are used in clinical diagnostics and pharma R&D for particularly demanding applications, and in biomarker panels to characterize changes in health, disease, and treatment in longitudinal user-collected dried blood microsamples. Siscapa immuno-affinity mass spectrometry assays for targeted protein quantitation can be developed more quickly than typical ELISA immunoassays since they require only a single specific antibody and provide absolute target specificity because of the MS detection. Because Siscapa assays do not interact with one another, these assays can be freely assembled in panels for various applications. The American company was founded by N. Leigh Anderson, who has been the CEO since incorporation. | 13 Jahre |
| Reno Pontarollo | M | - |
Eyam Vaccines & Immunotherapeutics Ltd.
| 4 Jahre |
| Mei Mei Tian | M | - | 12 Jahre | |
| Graeme Dick | M | - | 13 Jahre | |
| James E. LaBelle | M | - |
Eyam Vaccines & Immunotherapeutics Ltd.
| 3 Jahre |
| Lyle Oberg | M | 63 |
Eyam Vaccines & Immunotherapeutics Ltd.
| - |
| Elizabeth Jobes | F | 57 |
Eyam Vaccines & Immunotherapeutics Ltd.
| 3 Jahre |
| John S. MacDonald | M | - |
Science Council of British Columbia
| - |
| Pamela Lincez | M | - |
Eyam Vaccines & Immunotherapeutics Ltd.
| 3 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| David J. Clark | M | 68 | 8 Jahre | |
| Mark Day | M | 52 | 2 Jahre | |
| Ronald Erickson | M | 80 | 7 Jahre | |
| Mahalakshmi Radhakrishnan | M | - | 1 Jahre | |
| Catherine London | F | - | - | |
| Judith F. Dalling | F | 69 | 3 Jahre | |
| J. Hutchison | M | 68 | 9 Jahre | |
| H. Christian Fibiger | M | 80 | 7 Jahre | |
| Gregory Gubitz | M | 66 | 5 Jahre | |
| Nancy E. Stagliano | M | 57 | 2 Jahre | |
| David T. Howard | M | 74 | 1 Jahre | |
| Hugh MacNaught | M | - | - | |
| Reinhard Gabathuler | M | - | - | |
| Karoly Nikolich | M | - | 2 Jahre | |
| Craig Dalton Thomas | M | 72 | - | |
| Doug Williams | M | - | - | |
| George Sanders | M | - | 4 Jahre | |
| John Michael Hutchison | M | 80 | 6 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 23 | 65,71% |
| Kanada | 12 | 34,29% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Terry Pearson
- Persönliches Netzwerk